AT
PFE icon

Arlington Trust’s Pfizer PFE Stock Holding History

Arlington Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74K Buy
280
+38
+16% +$994 ﹤0.01% 521
2026
Q1 		$6.79K Buy
+242
New +$6.44K ﹤0.01% 487
2025
Q4 		– Sell
-1,527
Closed -$38.9K – 583
2025
Q3 		$38.9K Hold
1,527
– – 0.01% 383
2025
Q2 		$37K Sell
1,527
-2,850
-65% -$66.5K 0.01% 388
2025
Q1 		$111K Sell
4,377
-2,631
-38% -$68.8K 0.02% 248
2024
Q4 		$186K Sell
7,008
-3,805
-35% -$103K 0.04% 188
2024
Q3 		$313K Sell
10,813
-388
-3% -$11.3K 0.07% 126
2024
Q2 		$313K Buy
11,201
+6,801
+155% +$187K 0.07% 119
2024
Q1 		$122K Sell
4,400
-131
-3% -$3.63K 0.03% 195
2023
Q4 		$130K Buy
4,531
+2,771
+157% +$83.8K 0.04% 185
2023
Q3 		$58.4K Buy
+1,760
New +$62.2K 0.02% 132

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arlington Trust's PFE Position: Q2 2026 in Review

Arlington Trust increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $994 and bringing the position to 280 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Arlington Trust first reported a position in PFE in Q3 2023 and has held it in 11 quarters since. The position peaked at $313K in Q2 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Arlington Trust held 280 shares of Pfizer worth $6.74K as of Q2 2026.
  • Arlington Trust bought 38 Pfizer shares in Q2 2026, an estimated $994.
  • Pfizer made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #521 holding.
  • Arlington Trust first reported a position in Pfizer in Q3 2023 and has held it in 11 quarters since.
  • Arlington Trust's Pfizer position peaked at $313K in Q2 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.